[Dependence of various methods of control of renal function on the water-salt content of the organism and on the level of activity of the adrenergic system].
G C
GC
Agnoli
M
M
Cacciari
G
G
Cocco
C
C
Garutti
P
P
Lenzi
D000320:Adrenergic Fibers / Q000502:physiology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000328:Adult; D004837:Epinephrine / Q000502:physiology*; D005246:Feedback; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005947:Glucose / Q000009:adverse effects; D006801:Humans; D017136:Ion Transport; D007668:Kidney / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology*; D007686:Kidney Tubules, Distal / Q000187:drug effects / Q000503:physiopathology; D009318:Natriuresis / Q000187:drug effects; D011141:Polyuria / Q000139:chemically induced / Q000150:complications; D011224:Prazosin / Q000494:pharmacology* / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D012964:Sodium / Q000378:metabolism; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D012964:Sodium; D011433:Propranolol; D005947:Glucose; D011224:Prazosin; D004837:Epinephrine